Keeping Current

521 Odcinki

1. Treating MS Early: Who, How, and When?

   Opublikowany: 14.06.2021
2. Bispecific Antibodies: The Case for Non-BCMA Targets

   Opublikowany: 11.06.2021
3. Tackling Adherence in Dyslipidemia: Concrete Actions for Better Outcomes

   Opublikowany: 4.06.2021
4. SARS-CoV-2 Vaccine Candidates: Expertise and Updates

   Opublikowany: 4.06.2021
5. Practical Strategies to Overcome Poor Vaccine Uptake During the COVID-19 Pandemic

   Opublikowany: 4.06.2021
6. COVID-19: The Path to Immunity

   Opublikowany: 3.06.2021
7. Optimal Implementation of the COVID-19 Vaccine: Best Practice and Strategies for Success

   Opublikowany: 2.06.2021
8. Beyond Clinical Trials: Treating nAMD in Clinical Practice

   Opublikowany: 27.05.2021
9. Molecularly Guided Therapy in Oncology Practice: The Evolving State of the Art

   Opublikowany: 25.05.2021
10. ENDO 2021 – New Directions With Weight Loss Concepts of the Future

    Opublikowany: 25.05.2021
11. Taking Control of Chronic Spontaneous Urticaria: A Tale of Two Perspectives

    Opublikowany: 19.05.2021
12. Advances in Oncogene-Driven Metastatic NSCLC: Focusing on EFGR Exon 20 Insertions and ALK-Positive NSCLC

    Opublikowany: 11.05.2021
13. HFpEF Is Arguably the Greatest Unmet Need in Cardiology: The Potential Role of SGLT2 Inhibitors

    Opublikowany: 6.05.2021
14. Patient Engagement in MS: What Does This Mean and What Does It Look Like?

    Opublikowany: 5.05.2021
15. Neuro-Ophthalmology: What You Need to Know About LHON

    Opublikowany: 30.04.2021
16. The Science of MS and Role of S1P Receptor Modulators

    Opublikowany: 30.04.2021
17. Emerging Therapies for Chronic Spontaneous Urticaria: Understanding How They Work

    Opublikowany: 21.04.2021
18. Molecular Testing – Transplant and Treatment Strategies in AML

    Opublikowany: 21.04.2021
19. New Approaches to Ocular Surface Pain

    Opublikowany: 19.04.2021
20. Defining NASH As a Metabolic Disease: Can We Afford to Ignore It?

    Opublikowany: 19.04.2021